Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation

Published:2022-02 Issue:2 Volume:28 Page:76-82
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Fuchida Shin-ichi^ORCID,Kawamura Koji,Sunami Kazutaka,Tsukada Nobuhiro,Fujii Shiro,Ohkawara Hiroshi,Usuki Kensuke,Wake Atsushi^ORCID,Endo Shinya^ORCID,Ishiyama Ken^ORCID,Ueda Yasunori^ORCID,Nakamura Yukinori^ORCID,Miyamoto Toshihiro,Fukuda Takahiro,Ichinohe Tatsuo^ORCID,Atsuta Yoshiko^ORCID,Takamatsu Hiroyuki

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference36 articles.

1. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only;Skinner;Am J Med.,1996

2. Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis;Palladini;Blood.,2007

3. A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis;Palladini;Blood,2015

4. Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate;Gertz;Bone Marrow Transplant.,2004

5. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study;Skinner;Ann Intern Med.,2004

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous stem cell transplantation in AL amyloidosis: Muddy waters;Blood Reviews;2024-08

2. Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management;Journal of Clinical Medicine;2024-03-18

3. Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodies;The Lancet Haematology;2023-11

4. VII. Pathophysiology, Diagnosis and Treatment of AL Amyloidosis;Nihon Naika Gakkai Zasshi;2023-07-10

5. A comprehensive overview of AL amyloidosis disease characteristics accumulated over two decades at a single referral center in Korea;International Journal of Hematology;2022-12-27